Chapter 15: Viral Skin Infections

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

You know, we often get taught to think of the skin as this impenetrable brick wall, like a castle fortress designed to keep the bad stuff out and, you know, the good stuff in.

Right.

It's a nice analogy, but the more you study dermatology, the more you realize it's, well, it's fundamentally flawed.

Exactly.

The skin is far too dynamic to just be a dumb wall.

It is much more like an active, highly selective border checkpoint.

You have guards, you have surveillance, you have cells constantly checking molecular passports, basically.

Right.

And when you step into the world of viral skin infections, you are dealing with microscopic invaders carrying perfectly forged documents.

I mean, they don't just breach the checkpoint, they hijack the guards entirely.

Which is exactly why diagnosing these infections can feel like navigating through absolute diagnostic muddy waters.

The virus is, well, it's using the host's own biology to mask its presence.

Welcome to the Deep Dive.

We are speaking directly to you, the Advanced Practice Nursing student.

Consider this your one -on -one tutoring session to master Chapter 15, Viral Skin Infections from Your Text, Primary Care, The Art and Science of Advanced Practice Nursing, 6th Edition.

Glad to be here.

So today we are focusing all our attention on two major viral culprits,

human papillomavirus, which causes warts, and herpes simplex virus, or HSV.

And our ultimate goal today isn't just memorizing a sterile list of pharmacologic treatments.

We want to understand exactly why these viruses behave the way they do on a cellular level.

Because once you understand the pathophysiology, right, the diagnostics and the management plans just stop being things you have to memorize.

Exactly.

They become incredibly intuitive.

So if we are looking at viruses that hijack the skin's border checkpoint,

I feel like the most common, seemingly mundane example you will see in clinical practice is the wart.

Oh, absolutely.

Patients brush them off as an annoyance all the time.

But the viral machinery behind an HPV infection is actually staggering when you look closely.

Let's unpack this.

How does HPV actually set up shop?

Well, it is a master class in cellular manipulation.

Epidemiology -wise, HPV is incredibly common, but it's also exceptionally picky.

It is entirely species -specific.

Right.

So it only targets human epithelial cells.

Exactly.

Specifically showing a strong tropism for keratinocytes and mucous membranes.

And you will typically see peak incidences in children, usually between the ages of 12 and 16.

And the risk factors are just, you know, everyday life.

Walking barefoot in a locker room, handling raw meat as an occupation, biting your nails, public pools.

Yeah.

And plus, patients who are immunosuppressed or have pre -existing atopic conditions like eczema.

Because they have a compromised scene barrier to begin with.

Right.

Which puts them at a much higher risk.

The virus is purely opportunistic.

It's just waiting for a microscopic break in the skin or the mucosa.

But it doesn't just sit on the surface, right?

And it also doesn't invade the bloodstream.

No, it doesn't.

Once it enters through that microscopic fissure, it gets into the epithelial cells and forces a hyperproliferation of the keratinocytes.

So it basically turns the cells into a localized factory.

Exactly.

It holds this dense hyperkeratotic mass.

But here is the critical clinical distinction.

It forms that mass only in the epidermis.

Wait, really?

Only the epidermis?

Yes.

It absolutely does not extend down into the dermis or the subcutaneous tissue.

Wow.

Which completely shatters one of the biggest clinical myths you will hear from patients.

I mean, they will come into the clinic entirely convinced that their wart has a root that extends deep into their flesh.

Oh, and they'll ask you to dig it out.

Yes.

This is a very persistent myth.

But the reality is that the underside of a wart is perfectly smooth and round.

There are no roots.

Right.

And explaining that to a patient is a crucial piece of education that honestly immediately deescalates their anxiety about treatment.

Because when we look at the clinical presentation, the diagnostic hallmark of a wart is this uniform mosaic pattern.

You have these tightly fused cylindrical projections.

But patients always point to the black dots on the surface as proof of those roots.

Right.

But those black dots are fascinating.

They are actually thrombosed capillaries.

Oh, wow.

Yeah.

As the wart hyperproliferates and builds those cylindrical finger -like projections, it traps tiny blood vessels inside.

The vessels thrombose, or clot, and appears black dots on the surface.

That makes so much sense.

We also have to address the sheer variety of the virus, though.

There are, what, over 200 genomically distinct strains of HPV?

Over 200, yes.

Your common warts are primarily driven by serotypes 2 and 4.

Flat warts are usually 3, 10, and 28.

And plantar warts on the feet are 1, 2, 4, 27, and 57.

Right.

But for you, as an advanced practice nurse, the stakes get significantly higher when we talk about the mucosal strains.

Because that is where the clinical reasoning shifts from treating a localized nuisance to, well, preventing systemic malignancy.

Exactly.

Strains 16 and 18 are the high -risk culprits.

They are associated with over 90 % of anal and cervical cancers, 70 % of vulvar and vaginal cancers, and 60 % of penile malignancies.

That's huge clinical flag.

It really is.

Meanwhile, strains 6 and 11 are responsible for about 90 % of anogenital warts.

Knowing those specific serotypes completely dictates how you triage, screen, and counsel your patient.

So visualization in the clinic is where the rubber meets the road.

Common warts, or verruca vulgaris, typically start as smooth, flesh -colored papules, right?

Yeah.

And they grow into dome -shaped gray -brown masses, usually on hands and knees.

Then you have filiform warts, which look like little finger -like projections, and often pop up on the face.

Right.

And you also have to watch out for flat warts, or verruca plana.

They love to populate shaved areas.

Oh, so you will literally see a linear track of them.

Exactly.

Where a patient has dragged a razor across their skin, micro -tearing the epidermis and spreading the viral particles along the shave line.

That's wild.

And then there are the deep palma plantar warts.

These occur at pressure points, like the metatarsal heads on the bottom of the foot.

Right.

And because of the constant pressure of walking,

a thick,

incredibly painful callus forms around the wart, which essentially pushes it inward.

And this creates a really fascinating secondary clinical issue.

A patient with a painful plantar wart will subconsciously alter their gait to avoid putting weight on that metatarsal head.

Yeah.

Which means this subtle distortion in their posture can lead to secondary pain in their leg, or even their lower back.

It's just wild to think that a patient could come in complaining of lower back pain, and a thorough physical assessment reveals the root cause is actually an HPV infection on the sole of their foot.

It happens.

But this brings up a massive diagnostic challenge.

How do you confidently prove it is a wart and not just a regular friction callus or a corn?

Okay.

Yeah.

Because your most reliable diagnostic tool in the clinic is pairing the lesion with a number 15 scalpel blade.

So I have to play the role of the terrified new practitioner here.

If I am holding a scalpel to a patient's foot and I pair down a lesion and it immediately starts bleeding,

my heart is going to skip a beat.

Oh, for sure.

My immediate instinct is going to be that I slice too deep and hit the highly vascular dermis.

There is a completely natural fear.

But remember what we discussed about the pathophysiology.

A wart traps those thrombosed capillaries within its structure in the epidermis.

Right.

The black dots.

Exactly.

When you pair a wart with a blade, you are slicing the tops off those trapped capillaries, the black dots, which is why they bleed in that distinct pinpoint pattern.

So the pinpoint bleeding is actually the exact diagnostic confirmation I am looking for.

Precisely.

If you are dealing with a corn, it has a hard, painful, translucent central core and the normal skin lines will actually remain intact across the surface of a corn.

Okay.

Warts have no skin lines crossing them.

Right.

And if you pair a corn, you relieve the patient's pain once you free that hard central kernel, but it will not bleed in that pinpoint capillary pattern.

What if a runner comes in with a black spot on the heel of their foot?

Because a shearing injury from running can cause calcaneal patechia, basically bruised capillaries, that look exactly like a black wart.

You have to rely on the history there.

If they are a runner with new footwear, you suspect trauma.

But if it is a true black wart, that dark coloration is actually a fantastic sign.

Wait, really?

Yeah.

It indicates the wart is undergoing spontaneous resolution.

Wait, so if a black wart means the body's cell -mediated immune system has finally recognized the HPV -infected keratinocytes and is actively clearing them out, does that mean we shouldn't even treat it?

That is the exact clinical reasoning you need to apply.

Because there is no absolute cure for HPV.

The clinical consensus shows that half of all warts resolve without any treatment within one year, and two -thirds resolve within two years.

So watchful waiting is a highly valid evidence -based management strategy.

Absolutely, assuming the warts aren't causing severe pain or intense psychosocial distress.

But when we do step in to treat, the priority has to be patient safety.

We want to destroy the infected epidermis without scarring the underlying dermis.

I know for years, patients have sworn by the duct tape cure they read about online.

Here's where it gets really interesting though.

The recent literature actually debunks duct tape therapy as a standalone cure, right?

It does.

Duct tape occlusion alone has little to no clinical effectiveness.

However, it is still a very useful tool for occluding the area when combined with topical pharmacologic interventions just to increase their absorption.

So the actual first -line treatments for common warts usually come down to two primary options, 17 % salicylic acid or liquid nitrogen cryotherapy.

Right.

Salicylic acid works through keratosis.

You apply it, cover it with tape, and over a few days, it destroys the infected tissue, forming a soft white keratin layer.

And then the patient or provider gently pairs that dead white tissue away, and the cycle repeats.

Exactly.

Now, for more stubborn lesions, practitioners might pull out heavier chemical agents like bichloroacetic acid or trichloroacetic acid, BCA, and TCA.

Those are strictly provider applied though, right?

Yes, strictly provider applied.

They are highly caustic agents that destroy the wart by chemically coagulating the cellular proteins.

Yikes.

Yeah, they are technically self -neutralizing.

But because they are so destructive, you must meticulously protect the surrounding healthy skin with a barrier like petrol atom before applying the acid with a precision cotton -tipped applicator.

You definitely wouldn't use something that caustic on the face.

I mean, flat warts are a completely different challenge because they are in highly cosmetically sensitive areas.

For flat warts, the clinical goal shifts entirely to minimal scarring.

The most effective approach is often 0 .05 % tretinoin cream applied nightly for about 12 weeks.

And you have the patient adjust the frequency to elicit just a fine scaling and very mild erythema.

Right.

If that fails, 5 -fluorosil undertake occlusion is a backup, but you have to counsel the patient heavily about the risk of permanent hyperpigmentation.

And then there is podophyllin resin, which comes with serious systemic warnings.

Huge warnings.

Podophyllin is strictly for external warts.

Because of a high risk of systemic absorption and neurological toxicity,

you are limited to treating a maximum of 10 square centimeters per session.

Wow, that's a strict limit.

And furthermore, the patient must wash it off one to four hours after application.

And it is absolutely contraindicated in pregnancy.

Which brings up a vital scenario.

Imagine a pregnant patient comes into the clinic seeking treatment for bothersome warts.

You have to navigate this incredibly carefully.

Very carefully.

I know some advanced clinics use intralesional injections of the MMR vaccine, measles, mumps, and rubella to stimulate a local immune response against the wart.

Which is highly effective in the general population.

But MMR is a live attenuated vaccine.

That makes it an absolute contraindication for your pregnant patient.

So what is safe for her?

Salicylic acid, provided it is applied to a small localized area for a short duration, is generally safe.

Liquid nitrogen cryotherapy is also considered safe during pregnancy, leaning toward light applications to prevent thermal injury to the melanocytes.

We also can't forget the holistic picture here.

If a patient wants their warts gone, they need to look at their habits.

Specifically, smoking.

Oh, absolutely.

Because cigarette smoking chemically weakens the immune system's surveillance and has actually been shown to enhance the expression of HPV.

Right, so counseling a patient to quit smoking is actually a direct intervention for clearing their viral skin infection.

It perfectly illustrates how dermatology is never just skin deep.

I love that.

And that concept is the perfect bridge to our second virus.

Because HPV builds these hyperkeratotic fortresses right on the surface.

But if a patient comes in a completely different presentation, fragile vesicles that appear, rupture, and then completely vanish, you are dealing with a virus that uses a totally different survival strategy.

Right, it doesn't build, it hides.

Exactly.

Which brings us to herpes simplex virus.

HSV is the ultimate stealth operator.

Epidemiologically, we used to draw a hard line.

HSV1 was oral and HSV2 was genital.

But the literature makes it clear that this line is rapidly blurring due to changes in oral genital sexual practices.

It is.

The global burden is staggering.

I mean, billions of people worldwide carry HSV1.

And the stakes here go far beyond a painful sore.

Having an HSV2 infection increases a patient's risk of acquiring HIV by three times.

The mucosal damage provides a direct portal of entry for other pathogens.

That is exactly why understanding the pathophysiology is so crucial here.

HSV infection occurs in two distinct phases.

The primary infection happens when the virus enters the keratinocytes in the epidermis and replicates, causing that initial outbreak.

But then it uses our own wiring against us.

Exactly.

It migrates to the local nerve endings and physically travels up the peripheral sensory nerves until it reaches the dorsal root ganglia.

And for oral strains, it usually targets the trigeminal ganglia.

For genital strains, it targets the sacral ganglia.

Spot on.

And once it gets into that nerve bundle, it enters a latent stage.

No active replication.

It just sits there, completely invisible to the immune system for months, years, or even a lifetime.

Until a trigger like, you know, stress, sunlight, or a fever causes it to reactivate, travel back down that exact same nerve pathway, and erupt on the skin.

Right.

And the tissue destruction you see on the skin isn't just from the virus replicating.

It's a war zone created by the host's own cellular immune response.

Right.

The CD4 and CD8 T cells, macrophages, and natural killer cells flood the area.

Yes, releasing cytotoxic cytokines like interferon gamma to destroy the infected cells.

Which gives us that classic clinical presentation.

You will see grouped vesicles sitting on an erythematous red base.

They eventually ulcerate, crust over with a distinct honey color, and typically heal in seven to ten days without scarring.

But your assessment has to account for special populations too, like herpetic Whitlow.

Oh, the finger infection.

Right.

It's an intensely painful HSV infection on the fingertip.

We used to see it constantly in dental and healthcare workers before universal gloving.

But today, you will mostly see it as auto -inoculation in a child who sucks their thumb while having a cold sore, or a woman with genital HSV.

You also have eczema herpetica, which is a severe, widespread HSV eruption in patients with pre -existing atopic dermatitis.

Yes.

That can be very serious.

But the one that really requires strong clinical reasoning is erythema multiform.

I mean, a patient who recently recovered from a standard HSV outbreak suddenly presents with these symmetric, iris -shaped, target -like lesions on the palms of their hands and the soles of their feet.

It looks like a completely different disease.

But it is actually a systemic hypersensitivity reaction triggered by the fragmented DNA of the herpesvirus.

Speaking of systemic, we need to talk about the absolute red flags.

Imagine a patient is brought into the ER, they have an altered level of consciousness, erratic personality changes, and they are reporting bizarre olfactory hallucinations.

Like smelling burning rubber when nothing is there.

Exactly.

What is that?

You immediately have to suspect herpetic encephalitis.

The virus has bypassed the standard pathways and infected the brain tissue.

It is a profound medical emergency requiring immediate hospitalization and intravenous acyclover.

Another red flag, particularly in older adults, is auto -inoculation of the eye, causing herpetic keratoconjunctivitis.

They will present with excessive tearing, intense photophobia, and purulent exudate.

And that is actually the most frequent cause of corneal blindness in the developed world, which is why taking a meticulous history is your absolute best diagnostic tool.

So what does this all mean for taking a patient history?

You must ask about prodromal symptoms.

Did they experience localized burning, tingling, or pain a day or two before the sores actually appeared?

Because viral shedding and transmission happens during that prodrome, before the vesicle even forms.

And if you suspect genital herpes, you cannot be shy.

You need to ask direct questions about exact sexual practices, oral, vaginal, anal.

Do they use latex condoms correctly and consistently?

Right.

And for female patients, you need to know if they have a history of abnormal pap smears, as the tissue changes can be related.

So you rely heavily on history and physical exam, but you still need laboratory confirmation.

Yes.

Viral culture remains a gold standard if you have an intact vesicle to sample.

But the timing is critical.

It must be done within the first 72 hours of the outbreak, or the viral load drops too low to culture.

And if you suspect a central nervous system infection, PCR testing is the standard.

Right.

I feel like the Zanksmear is one of those classic textbook tests that always comes up.

But realistically, if a Zanksmear just identifies multi -nucleated giant cells in the fascicular fluid, it can't actually differentiate between HSV1, HSV2, or varitella zoster virus shingles.

So why would a practitioner even use it?

Pure speed.

It is a rapid bedside test that confirms you are dealing with a herpes family virus rather than, say, a bacterial infection or an autoimmune blistering disease.

But you still need a culture or PCR for the exact typing.

Which makes the differential diagnosis so important.

Let's reason through a few.

If a patient comes in with a painful ulcer in their mouth, how do I know it's not just achthostomatitis -like, a common canker sore?

Look at the tissue type.

Aphostomatitis almost exclusively occurs on non -carotenized mucosa, so the inside of the cheeks or lips.

It is usually a solitary ulcer without any systemic fever.

And HSV oral lesions?

They typically occur on carotenized tissue, like the hard palate or the firmly attached gingiva.

What about hand, foot, and mouth disease?

I imagine that gets confused for HSV frequently in pediatric patients.

It does, but you can rule it out quickly by checking the anatomical distribution.

Hand, foot, and mouth presents with red macules that progress to vesicles, but they are localized to the extremities, the palms and soles, along with the oral cavity.

What about pemphigus vulgaris?

That is an autoimmune disorder, usually seen in older results, featuring distinctive large flaccid bullae that easily rupture.

It looks very different from the tightly grouped uniform vesicles in HSV.

And the trickiest one, varicella zosterovirus, or shingles, presenting on the back or buttocks, versus an HSV outbreak in the exact same area.

The primary clinical difference there is morphology.

HSV vesicles within a cluster are typically uniform in size and stage of development.

Varicella zoster lesions in a cluster will vary significantly in size and will often be in different stages of crusting and healing simultaneously.

Okay, that makes sense.

So once we had our diagnosis, we moved to management.

And I feel like the hardest thing to tell a patient is that there is no cure.

The clinical goals are entirely focused on symptom relief, reducing the duration of viral shedding, and preventing transmission to partners or neonates.

Right.

For initial oral herpes, the approach is largely palliative.

Acetaminophen for the pain,

over -the -counter docosanol, or Abrava, applied five times daily at the absolute first sign of a prodromal tingle.

But if you have an older adult with severe oral pain that is actually compromising their ability to eat or drink, you can prescribe oral anesthetics, right?

Yes.

Viscous lidocaine 2 % used as a swish and spit rinse before meals can provide enough temporary numbing to allow them to maintain hydration.

For genital herpes, initial treatment requires systemic oral antivirals.

When you are writing that prescription, valacyl clover and famsiclover are generally preferred over the older acyclover.

Right.

And the reasoning there is purely pharmacokinetic, right?

Valacyl clover has much greater bioavailability.

So instead of telling a patient they have to take a pill five times a day, which they inevitably will forget.

They only have to take it once or twice a day.

The compliance rates skyrocket.

Now, if a patient is experiencing frequent, highly distressing recurrences, defined clinically as six or more outbreaks per year, that is the indication to initiate daily expressive therapy.

Taking a daily antiviral.

Right.

It reduces the frequency of recurrences by 70 to 80 percent.

And crucially, it reduces the risk of viral transmission to a susceptible partner by about 50 percent.

I want to return to the topic of pregnancy.

Because managing HSV in a pregnant patient is an absolute non -negotiable clinical priority.

Yes.

Pregnant women with a pre -existing genital HSV infection, or one acquired during pregnancy,

must be prescribed suppressive antiviral therapy starting at 36 weeks gestation.

To prevent vertical transmission during vaginal delivery.

Exactly.

Neonatal herpes is devastating.

It can result in profound neurological disability,

disseminated systemic infection, or death.

The antivirals are proven safe in pregnancy,

and suppressing viral shedding at the time of labor can actually prevent the need for a cesarean delivery.

Beyond the pharmacology, we have to provide practical, everyday relief.

Counseling patients to use warm oatmeal sitz baths for genital lesions to soothe the nerve pain.

Advising them to use a standard hair blow dryer on the cool setting to thoroughly dry genital lesions after a shower, rather than causing painful friction with a towel.

We also have to recognize when a case exceeds our scope.

If you ever see Groot vesicles near the eyelid, or suspect herpetic keratoconjunctivitis, that is an immediate same -day referral to an ophthalmologist to prevent permanent vision loss.

And finally, we cannot ignore the profound psychosocial impact.

Diagnosing someone with genital herpes carries immense social stigma and emotional weight.

It really does.

A major part of your interprofessional management is referring your patients to local advocacy organizations and resources like the American Sexual Health Association.

They help patients cope with the diagnosis, learn how to have difficult conversations with future sexual partners, and process the emotional toll.

Because as an advanced practice nurse, you are never just treating a viral skin lesion, you are helping a human being navigate a complex, lifelong condition.

Absolutely.

So to recap our journey through the skin's border checkpoint today, we started by looking at how HPV acts as a localized factory, building hyperkeratotic fortresses in the epidermis.

Then we tracked the stealthy, latent pathways of HSV, exploring how it retreats up the peripheral nerves to hide in the ganglia, only to return and trigger targeted tissue destruction.

It forces you to appreciate just how dynamic and intricate the skin's immune surveillance truly is.

It really does.

And before we close this session, I want to leave you with a deeply fascinating pathophysiological concept, from the text to mull over.

We discussed how traditional CD4 and CD8 T cells from the systemic immune system flood the skin to fight off HSV.

But recent animal models suggest that protection against severe mucocutaneous HSV relies heavily on something else entirely.

Right.

It involves non -classical T cells that are endogenous, meaning they are natively stationed within the skin and mucosal surfaces themselves.

And unlike the systemic T cells, these local guards express distinct gamma delta antigen receptors.

Which raises an incredible question.

Could the future of viral skin management lie in developing targeted therapies that activate these hyperlocal gamma delta T cells right at the skin's border checkpoint, rather than relying on systemic antiviral medications?

It completely shifts the paradigm of how we might treat localized infections in the future.

It is a brilliant area of ongoing research that proves how much we still have to learn about the cutaneous immune system.

The skin is definitely not just a brick wall.

We hope this deep dive has armed you with the path of physiological understanding and the clinical reasoning you need to excel in your practice and dominate your exams.

Sending a warm thank you from the Last Minute Lecture Team and wishing you the absolute best of luck on your clinicals.

Keep asking the right questions.